Clinical Trials Directory

Trials / Unknown

UnknownNCT06323642

Role of Probiotics as Adjunct Therapy Along With Standard Care in Decreasing Hospital Stay and Improving Symptoms in Pediatric Patients Admitted With Severe Pneumonia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University · Academic / Other
Sex
All
Age
6 Months – 2 Years
Healthy volunteers
Not accepted

Summary

Probiotics as adjuvant therapy along with standard care can decrease hospital stay and improve symptoms (fever, tachypnea,cough) in pediatric patients admitted with severe pneumonia.

Detailed description

After getting written informed consent from parents/attendants, all patients aged 6 month-2yrs admitted with severe pneumonia in pediatric wards of children hospital, during the study time of 6 month will be recruited.After applying exclusion criteria remaining participants will be included in the study. The study population will be randomized in to two groups, Group A will be given probiotic sachet and group B will be given simple milk as placebo.The patients and their parents/attendants will be kept blind to the fact that they are receiving either probiotic or placebo The probiotic and placebo mixture will be given daily for three days.The patients in both the groups will be followed for the duration of illness until they are either discharged or show any adverse outcomes of pneumonia.Total days of admission will be recoded for patients discharged from hospital.Parents will be asked questions regarding improvement in symptoms like fever on discharge. Duration for Improvement in tachypnea andcough will be noted for all patients. Outcomes will be duration of hospital admission, improvement in fever, tachypnea and cough.All the data collected will be entered and analyzed using SPSS latest version and analysed.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTprobiotic containing Lactobacillus rhamnosus GG.probiotic containing Lactobacillus rhamnosus GG will be given daily for 3 days
OTHERplacebomilk as placebo

Timeline

Start date
2023-09-01
Primary completion
2024-03-31
Completion
2024-03-31
First posted
2024-03-21
Last updated
2024-03-21

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06323642. Inclusion in this directory is not an endorsement.